Literature DB >> 11566500

Changes in the mRNAs encoding voltage-gated sodium channel types II and III in human epileptic hippocampus.

W R Whitaker1, R L Faull, M Dragunow, E W Mee, P C Emson, J J Clare.   

Abstract

Studies with animal seizure models have indicated that changes in temporal and spatial expression of voltage-gated sodium channels may be important in the pathology of epilepsy. Here, by using in situ hybridisation with previously characterised subtype-selective oligonucleotide probes [Whitaker et al. (2000) J. Comp. Neurol. 422, 123-139], we have compared the cellular expression of all four brain alpha-subunit sodium channel mRNAs in "normal" and epileptic hippocampi from humans. Neuronal cell loss was observed in all regions of the hippocampus of diseased patients, indicating that sclerosis had occurred. Losses of up to 40% compared to post-mortem controls were observed which were statistically significant in all regions studied (dentate gyrus, hilus, and CA1-3). To assess mRNA levels of the different alpha-subtypes in specific subregions, control and diseased tissue sections were hybridised to subtype-specific probes. To quantify any changes in expression while allowing for cell loss, the sections were processed for liquid emulsion autoradiography and grain counts were performed on populations of individual neurones in different subregions. No significant differences were found in the expression of type I and VI mRNAs. In contrast, a significant down-regulation of type II mRNA was observed in the epileptic tissue in the remaining pyramidal cells of CA3 (71+/-7% of control, P<0.01), CA2 (81+/-8% of control, P<0.05) and CA1 (72+/-6% of control, P<0.05) compared with control tissue. Additionally, a significant up-regulation in type III mRNA in epileptic CA4 pyramidal cells (145+/-7% of control, P<0.05) was observed. It is not clear whether these changes play a causal role in human epilepsy or whether they are secondary to seizures or drug treatment; further studies are necessary to investigate these alternatives. However, it is likely that such changes would affect the intrinsic excitability of hippocampal neurones.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566500     DOI: 10.1016/s0306-4522(01)00212-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  22 in total

1.  In silico docking and electrophysiological characterization of lacosamide binding sites on collapsin response mediator protein-2 identifies a pocket important in modulating sodium channel slow inactivation.

Authors:  Yuying Wang; Joel M Brittain; Brian W Jarecki; Ki Duk Park; Sarah M Wilson; Bo Wang; Rachel Hale; Samy O Meroueh; Theodore R Cummins; Rajesh Khanna
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  Promoter analysis of mouse Scn3a gene and regulation of the promoter activity by GC box and CpG methylation.

Authors:  Guang-Fei Deng; Jia-Ming Qin; Xun-Sha Sun; Zu-Ying Kuang; Tao Su; Qi-Hua Zhao; Yi-Wu Shi; Xiao-Rong Liu; Mei-Juan Yu; Yong-Hong Yi; Wei-Ping Liao; Yue-Sheng Long
Journal:  J Mol Neurosci       Date:  2011-01-27       Impact factor: 3.444

Review 3.  Ion channels as drug targets in central nervous system disorders.

Authors:  A M Waszkielewicz; A Gunia; N Szkaradek; K Słoczyńska; S Krupińska; H Marona
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

4.  Sodium-potassium ATPase emerges as a player in hippocampal phenotypes of Angelman syndrome mice.

Authors:  Jada J Hallengren; Ryan J Vaden
Journal:  J Neurophysiol       Date:  2014-02-05       Impact factor: 2.714

5.  Novel SCN3A variants associated with focal epilepsy in children.

Authors:  Carlos G Vanoye; Christina A Gurnett; Katherine D Holland; Alfred L George; Jennifer A Kearney
Journal:  Neurobiol Dis       Date:  2013-10-21       Impact factor: 5.996

6.  Exploring the genomic basis of pharmacoresistance in epilepsy: an integrative analysis of large-scale gene expression profiling studies on brain tissue from epilepsy surgery.

Authors:  Nasir Mirza; Olga Vasieva; Anthony Guy Marson; Munir Pirmohamed
Journal:  Hum Mol Genet       Date:  2011-08-18       Impact factor: 6.150

7.  Pro-excitatory alterations in sodium channel activity facilitate subiculum neuron hyperexcitability in temporal lobe epilepsy.

Authors:  Bryan S Barker; Aradhya Nigam; Matteo Ottolini; Ronald P Gaykema; Nicholas J Hargus; Manoj K Patel
Journal:  Neurobiol Dis       Date:  2017-08-30       Impact factor: 5.996

8.  BACE1 regulates voltage-gated sodium channels and neuronal activity.

Authors:  Doo Yeon Kim; Bryce W Carey; Haibin Wang; Laura A M Ingano; Alexander M Binshtok; Mary H Wertz; Warren H Pettingell; Ping He; Virginia M-Y Lee; Clifford J Woolf; Dora M Kovacs
Journal:  Nat Cell Biol       Date:  2007-06-18       Impact factor: 28.824

9.  A BAC transgenic mouse model reveals neuron subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS+) mutation.

Authors:  Bin Tang; Karoni Dutt; Ligia Papale; Raffaella Rusconi; Anupama Shankar; Jessica Hunter; Sergio Tufik; Frank H Yu; William A Catterall; Massimo Mantegazza; Alan L Goldin; Andrew Escayg
Journal:  Neurobiol Dis       Date:  2009-05-03       Impact factor: 5.996

10.  Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry.

Authors:  Mirko Rivara; Manoj K Patel; Laura Amori; Valentina Zuliani
Journal:  Bioorg Med Chem Lett       Date:  2012-08-23       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.